ASX - By Stock
|
WEB |
Re:
Dilution Calculation
|
|
no vice
|
54 |
30K |
3 |
20/05/20 |
20/05/20 |
ASX - By Stock
|
54
|
30K
|
3
|
|
ASX - By Stock
|
WEB |
Re:
Ann: Webjet delivers on international WebBeds strategy
|
|
no vice
|
257 |
1.4M |
6 |
15/05/20 |
15/05/20 |
ASX - By Stock
|
257
|
1.4M
|
6
|
|
ASX - By Stock
|
PAA |
Re:
LIKE A SAILOR.
|
|
no vice
|
10 |
3.2K |
4 |
13/05/20 |
13/05/20 |
ASX - By Stock
|
10
|
3.2K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Monepantel Trial Achieves Successful Anti-Cancer Outcome
|
|
no vice
|
438 |
120K |
6 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
438
|
120K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Monepantel Trial Achieves Successful Anti-Cancer Outcome
|
|
no vice
|
438 |
120K |
8 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
438
|
120K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
What time will the Trading halt lift?
|
|
no vice
|
67 |
17K |
4 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
67
|
17K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Seventy Reason to Buy PAA
|
|
no vice
|
273 |
68K |
16 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
273
|
68K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
What time will the Trading halt lift?
|
|
no vice
|
67 |
17K |
5 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
67
|
17K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
no vice
|
202 |
63K |
13 |
09/05/20 |
09/05/20 |
ASX - By Stock
|
202
|
63K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to Evaluate Monepantel on COVID-19
|
|
no vice
|
315 |
88K |
12 |
07/05/20 |
07/05/20 |
ASX - By Stock
|
315
|
88K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to Evaluate Monepantel on COVID-19
|
|
no vice
|
315 |
88K |
14 |
06/05/20 |
06/05/20 |
ASX - By Stock
|
315
|
88K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to Evaluate Monepantel on COVID-19
|
|
no vice
|
315 |
88K |
4 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
315
|
88K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to Evaluate Monepantel on COVID-19
|
|
no vice
|
315 |
88K |
11 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
315
|
88K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to Evaluate Monepantel on COVID-19
|
|
no vice
|
315 |
88K |
2 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
315
|
88K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to Evaluate Monepantel on COVID-19
|
|
no vice
|
315 |
88K |
7 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
315
|
88K
|
7
|
|
ASX - By Stock
|
FLT |
Re:
Institution stock hitting the market
|
|
no vice
|
83 |
38K |
0 |
25/04/20 |
25/04/20 |
ASX - By Stock
|
83
|
38K
|
0
|
|
ASX - By Stock
|
AVQ |
Re:
Investing in the Solomon Islands.
|
|
no vice
|
23 |
13K |
9 |
25/04/20 |
25/04/20 |
ASX - By Stock
|
23
|
13K
|
9
|
|
ASX - By Stock
|
FLT |
Re:
Institution stock hitting the market
|
|
no vice
|
83 |
38K |
3 |
25/04/20 |
25/04/20 |
ASX - By Stock
|
83
|
38K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
PAA Shareholder Questions - Comments for 2019 AGM.
|
|
no vice
|
136 |
52K |
1 |
30/10/19 |
30/10/19 |
ASX - By Stock
|
136
|
52K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
PAA Shareholder Questions - Comments for 2019 AGM.
|
|
no vice
|
136 |
52K |
3 |
30/10/19 |
30/10/19 |
ASX - By Stock
|
136
|
52K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
PAA Shareholder Questions - Comments for 2019 AGM.
|
|
no vice
|
136 |
52K |
2 |
30/10/19 |
30/10/19 |
ASX - By Stock
|
136
|
52K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: AGM Presentation
|
|
no vice
|
69 |
27K |
1 |
25/10/19 |
25/10/19 |
ASX - By Stock
|
69
|
27K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: AGM Presentation
|
|
no vice
|
69 |
27K |
3 |
25/10/19 |
25/10/19 |
ASX - By Stock
|
69
|
27K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
PAA Shareholder Questions - Comments for 2019 AGM.
|
|
no vice
|
136 |
52K |
4 |
25/10/19 |
25/10/19 |
ASX - By Stock
|
136
|
52K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
PAA Shareholder Questions - Comments for 2019 AGM.
|
|
no vice
|
136 |
52K |
1 |
24/10/19 |
24/10/19 |
ASX - By Stock
|
136
|
52K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
PAA Shareholder Questions - Comments for 2019 AGM.
|
|
no vice
|
136 |
52K |
3 |
24/10/19 |
24/10/19 |
ASX - By Stock
|
136
|
52K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
PAA Shareholder Questions - Comments for 2019 AGM.
|
|
no vice
|
136 |
52K |
3 |
24/10/19 |
24/10/19 |
ASX - By Stock
|
136
|
52K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust Phase II K9 Trial
|
|
no vice
|
559 |
241K |
6 |
23/10/19 |
23/10/19 |
ASX - By Stock
|
559
|
241K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
PAA Shareholder Questions - Comments for 2019 AGM.
|
|
no vice
|
136 |
52K |
6 |
22/10/19 |
22/10/19 |
ASX - By Stock
|
136
|
52K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Do we touch on $.20 this week
|
|
no vice
|
74 |
34K |
6 |
17/10/19 |
17/10/19 |
ASX - By Stock
|
74
|
34K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Do we touch on $.20 this week
|
|
no vice
|
74 |
34K |
7 |
17/10/19 |
17/10/19 |
ASX - By Stock
|
74
|
34K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust Phase II K9 Trial
|
|
no vice
|
559 |
241K |
5 |
11/10/19 |
11/10/19 |
ASX - By Stock
|
559
|
241K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust Phase II K9 Trial
|
|
no vice
|
559 |
241K |
15 |
05/10/19 |
05/10/19 |
ASX - By Stock
|
559
|
241K
|
15
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC Signs Agreement for Construction of GMP Pharma Facility
|
|
no vice
|
83 |
37K |
8 |
09/08/19 |
09/08/19 |
ASX - By Stock
|
83
|
37K
|
8
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Additional Information on Ground-breaking Research
|
|
no vice
|
86 |
31K |
2 |
01/08/19 |
01/08/19 |
ASX - By Stock
|
86
|
31K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Upcoming Expiry of Listed Options MXCOD
|
|
no vice
|
62 |
20K |
2 |
18/06/19 |
18/06/19 |
ASX - By Stock
|
62
|
20K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Plan B = competence
|
|
no vice
|
8 |
3.0K |
1 |
07/06/19 |
07/06/19 |
ASX - By Stock
|
8
|
3.0K
|
1
|
|
ASX - By Stock
|
RGT |
Re:
Plan B = competence
|
|
no vice
|
8 |
3.0K |
3 |
06/06/19 |
06/06/19 |
ASX - By Stock
|
8
|
3.0K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Material Revenues Confirmed from Non-Pharma Business Units
|
|
no vice
|
107 |
35K |
2 |
05/06/19 |
05/06/19 |
ASX - By Stock
|
107
|
35K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Upcoming Expiry of Listed Options MXCOD
|
|
no vice
|
62 |
20K |
3 |
02/06/19 |
02/06/19 |
ASX - By Stock
|
62
|
20K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Cultivation Licence Granted by the Office of Drug Control
|
|
no vice
|
54 |
19K |
7 |
30/05/19 |
30/05/19 |
ASX - By Stock
|
54
|
19K
|
7
|
|
ASX - By Stock
|
RGT |
Re:
CannaGlobal Website and Credibility
|
|
no vice
|
156 |
53K |
4 |
28/05/19 |
28/05/19 |
ASX - By Stock
|
156
|
53K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
CannaGlobal Website and Credibility
|
|
no vice
|
156 |
53K |
4 |
21/05/19 |
21/05/19 |
ASX - By Stock
|
156
|
53K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Mxc-social media
|
|
no vice
|
667 |
375K |
2 |
20/05/19 |
20/05/19 |
ASX - By Stock
|
667
|
375K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
CannaGlobal Website and Credibility
|
|
no vice
|
156 |
53K |
3 |
20/05/19 |
20/05/19 |
ASX - By Stock
|
156
|
53K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Today is turning point...
|
|
no vice
|
102 |
45K |
7 |
17/05/19 |
17/05/19 |
ASX - By Stock
|
102
|
45K
|
7
|
|
ASX - By Stock
|
RGT |
Re:
Today is turning point...
|
|
no vice
|
102 |
45K |
11 |
07/05/19 |
07/05/19 |
ASX - By Stock
|
102
|
45K
|
11
|
|
ASX - By Stock
|
RGT |
Re:
Mxc-social media
|
|
no vice
|
667 |
375K |
4 |
05/05/19 |
05/05/19 |
ASX - By Stock
|
667
|
375K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Mxc-social media
|
|
no vice
|
667 |
375K |
2 |
04/05/19 |
04/05/19 |
ASX - By Stock
|
667
|
375K
|
2
|
|
ASX - By Stock
|
RGT |
Re:
Ann: March Quarterly Activity and Cashflow Report
|
|
no vice
|
114 |
40K |
1 |
01/05/19 |
01/05/19 |
ASX - By Stock
|
114
|
40K
|
1
|
|